Delivery Order SPE2DB20D3103-SPE2DB22FL4F7

Award Date 10/22/21

Potential Completion Date 10/25/21

Potential Value $4.1K

Federal Agency

Defense Logistics Agency

Awardee

Amerisourcebergen Drug Corp KABZK8W6PQT3

Ultimate Awardee

Cencora, Inc. NWEGNLYTBDW4

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Conshohocken, PA 19428, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The federal contract award SPE2DB20D3103|SPE2DB22FL4F7 is for the delivery of OFIRMEV 1,000 MG/100 ML VIAL 100ML pharmaceutical products to the Defense Logistics Agency (DLA). The $4,073.72 contract was awarded on October 22, 2021 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense and Department of Veterans Affairs healthcare systems. The contract has a firm fixed price pricing type and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 9:58 AM